Reaction Details |
| Report a problem with these data |
Target | B2 bradykinin receptor |
---|
Ligand | BDBM50409527 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_40430 (CHEMBL876526) |
---|
Ki | 0.79±n/a nM |
---|
Citation | Dziadulewicz, EK; Ritchie, TJ; Hallett, A; Snell, CR; Davies, JW; Wrigglesworth, R; Dunstan, AR; Bloomfield, GC; Drake, GS; McIntyre, P; Brown, MC; Burgess, GM; Lee, W; Davis, C; Yaqoob, M; Phagoo, SB; Phillips, E; Perkins, MN; Campbell, EA; Davis, AJ; Rang, HP Nonpeptide bradykinin B2 receptor antagonists: conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists. J Med Chem45:2160-72 (2002) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
B2 bradykinin receptor |
---|
Name: | B2 bradykinin receptor |
Synonyms: | B2 BRADYKININ | B2 bradykinin receptor | B2R | BDKRB2 | BK-2 receptor | BKR2 | BKRB2_HUMAN | Bradykinin B2 receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 44467.17 |
Organism: | Homo sapiens (Human) |
Description: | B2 BRADYKININ BDKRB2 HUMAN::P30411 |
Residue: | 391 |
Sequence: | MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQVEWLGWLNTIQ
PPFLWVLFVLATLENIFVLSVFCLHKSSCTVAEIYLGNLAAADLILACGLPFWAITISNN
FDWLFGETLCRVVNAIISMNLYSSICFLMLVSIDRYLALVKTMSMGRMRGVRWAKLYSLV
IWGCTLLLSSPMLVFRTMKEYSDEGHNVTACVISYPSLIWEVFTNMLLNVVGFLLPLSVI
TFCTMQIMQVLRNNEMQKFKEIQTERRATVLVLVVLLLFIICWLPFQISTFLDTLHRLGI
LSSCQDERIIDVITQIASFMAYSNSCLNPLVYVIVGKRFRKKSWEVYQGVCQKGGCRSEP
IQMENSMGTLRTSISVERQIHKLQDWAGSRQ
|
|
|
BDBM50409527 |
---|
n/a |
---|
Name | BDBM50409527 |
Synonyms: | CHEMBL2112283 |
Type | Small organic molecule |
Emp. Form. | C35H46N8O6S |
Mol. Mass. | 706.855 |
SMILES | CN(C)CCCN(C)CCNC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(NNC(=O)NC2c3ccccc3CCc3ccccc23)c(c1)[N+]([O-])=O |r| |
Structure |
|